Vaccine Megathread - See OP for threadbans

Strazdas wrote: »

Very.....well over 70% I believe.

The HSE is reporting that data from England shows efficacy rising to 76% at preventing symptomatic Covid at 12 weeks, rising to 82% when dose 2 is given after the 12 weeks, and reaches full efficacy. Scottish data suggests that 4-5 weeks after the 1st dose, the risk of being admitted to hospital with severe Covid is reduced by 94%.

Earlier data from the trials is portrayed as AZ reducing symptomatic Covid by 60%, and reducing hospitalisation with severe Covid by 100%.

https://www2.hse.ie/screening-and-vaccinations/covid-19-vaccine/astrazeneca/immunity.html

Hococop wrote: »

How protected is someone off the first shot of az considering the potential 16 week wait for the 2nd jab?

Three weeks after receiving the first dose you will have 76% protection and 100% protection against severe Covid-19.

MerlinSouthDub wrote: »

Government considers delay to Pfizer second dose

https://m.independent.ie/irish-news/government-considers-delay-to-secondpfizer-jab-to-allow-more-people-to-get-first-dose-40309563.html

This needs to happen, certainly for those under 60.

Not sure how I feel about this. On the one hand we’d fly through the groups but then is it wrong to go against manufacturers advice?

Manach wrote: »

I agree. However here, there is a distinct lack of communication to the elderly housebound and their carers about when the housebound vaccination is due with the various state agencies shifting responsibility one to the other.

It is unreal honestly. The whole idea of lock downs was to protect the vulnerable and as soon as vaccines come they give them to the Serie A footballers first then 10 weeks laters say " oh maybe we should get the older people sorted now ":eek:

josip wrote: »

Am I the only one who gets apprehensive about future posting activity when I see this ?

You're not. I think it's very questionable why threads are being merged instead of the short ones locked and linked to post here instead. Some people are posting about rather specific things that aren't really to do with the general topic, maybe the loonies could be confined to a different thread instead of merging them here.

So if they know how to spot the adverse AZ reaction, and there’s treatment for it, why are we waiting around?

is_that_so wrote: »

Here's a piece on how one UK doctor both identified the potential AZ clotting issue and a diagnostic test for it.




https://www.theguardian.com/society/2021/apr/13/how-uk-doctor-marie-scully-blood-clotting-link-astrazeneca-covid-jab-university-college-london-hospital

First investigations into this was in Norway . It was reported on here . But of course the Norwegians were being blamed for being over cautious by UK at that stage .
Maybe this followed on from that , but at the time the Norwegians were discussing immune responses causing the CVST and antibodies being examined , the MHRA was saying nothing to see here .
I am pleased for this Dr Scully and that she has identified a diagnostic test , but really , the UK are forever banging their drum and give no credit to any other country or its scientists , especially if European .

Interesting article though

MerlinSouthDub wrote: »

Government considers delay to Pfizer second dose

https://m.independent.ie/irish-news/government-considers-delay-to-secondpfizer-jab-to-allow-more-people-to-get-first-dose-40309563.html

This needs to happen, certainly for those under 60.

Good

The more first doses we can get into people the better for the country

Johnson and Johnson have announced the suspension of their vaccine due to the finding of 6 cases of CVST in 7 million doses (less than one case per million), following on from the suspension of Astra Zeneca to all but the over 60s for the same reason. A quick google of peer-reviewed sources suggests that the incidence of CVST in the general population, pre-Covid, ranged from 7 per million to 15 per million. According to an article in the Irish Times( April 12th) there were 223 cases of CVST and another clotting issue (SVT) in 34 million AZ doses - a rate of about 6.5 per million.
I am no scientist, but the figures suggest that in the vaccinated population there is no greater incidence of CVST than would be expected in the unvaccinated population. In fact, in some studies it's considerably lower. Am I missing something?

Is that the one that essentially restarted trials?

Qrt wrote: »

Is that the one that essentially restarted trials?

I think they had smaller trials and are now preparing much larger scale trials.

I'll take the AstraZeneca, the Johnson & Johnson, the Sputnik, or the Sinovac vaccine. Tens of millions of people in the UK have had the AstraZeneca vaccine without any issue. Get the vaccines flowing ffs.

The zero risk approach is outrageous, pushed by people who are completely unaffected by the consequences of delaying the vaccine rollout.

Beasty wrote: »

Threads merged

Me nerves :pac:

GazzaL wrote: »

I'll take the AstraZeneca, the Johnson & Johnson, the Sputnik, or the Sinovac vaccine. Tens of millions of people in the UK have had the AstraZeneca vaccine without any issue. Get the vaccines flowing ffs.

The zero risk approach is outrageous, pushed by people who are completely unaffected by the consequences of delaying the vaccine rollout.

Completely agree, have reviews but keep vaccination program going while doing it.

I'm not anti lockdown etc but there isn't enough awareness on the damage done already and the damage done by prolonging.

There will be many more dead from the delay than the poor unfortunates who get the clot.

Neleven wrote: »

Johnson and Johnson have announced the suspension of their vaccine due to the finding of 6 cases of CVST in 7 million doses (less than one case per million), following on from the suspension of Astra Zeneca to all but the over 60s for the same reason. A quick google of peer-reviewed sources suggests that the incidence of CVST in the general population, pre-Covid, ranged from 7 per million to 15 per million. According to an article in the Irish Times( April 12th) there were 223 cases of CVST and another clotting issue (SVT) in 34 million AZ doses - a rate of about 6.5 per million.
I am no scientist, but the figures suggest that in the vaccinated population there is no greater incidence of CVST than would be expected in the unvaccinated population. In fact, in some studies it's considerably lower. Am I missing something?

It might be a clever move by Johnson & Johnson to suspend their own vaccine in Europe. It shows they are being responsible and are trying not to get themselves an AstraZeneca type reputation.